Literature DB >> 29425568

Time-to-isolation guided titration of freeze duration in 3rd generation short-tip cryoballoon pulmonary vein isolation - Comparable clinical outcome and shorter procedure duration.

Alexander Pott1, Christoph Kraft1, Tilman Stephan1, Kerstin Petscher1, Wolfgang Rottbauer1, Tillman Dahme2.   

Abstract

BACKGROUND: The optimal freeze duration in cryoballoon pulmonary vein isolation (PVI) is unknown. The 3rd generation cryoballoon facilitates observation of the time-to-isolation (TTI) and thereby enables individualized cryoenergy titration. To evaluate the efficacy of an individualized freeze duration we compared the clinical outcome of patients treated with a TTI-guided ablation protocol to the outcome of patients treated with a fixed ablation protocol.
METHODS: We compared 100 patients treated with the 3rd generation cryoballoon applying a TTI-based protocol (TTI group) to 100 patients treated by a fixed freeze protocol (fixed group). In the fixed group a 240s freeze cycle was followed by a 240s bonus freeze after acute PV isolation. In the TTI group freeze duration was 180s if TTI was ≥30s and reduced to only 120s, if TTI was <30s. In case of a TTI >60s a 180s bonus freeze was applied.
RESULTS: Freedom from atrial arrhythmia recurrence off class I/III antiarrhythmic drugs after one year was not different between the TTI group (73.6%) and the fixed group (75.7%; p=0.75). Mean procedure duration was 85.8±27.3min in the TTI group compared to 115.7±27.1min in the fixed group (p<0.001). Mean fluoroscopy time was 17.5±6.6min in the TTI group and 22.5±9.8min in the fixed group (p<0.001).
CONCLUSIONS: TTI-guided cryoenergy titration leads to reduced procedure duration and fluoroscopy time and appears to be as effective as a fixed ablation strategy. A single 2-minute freeze seems to be sufficient in case of short TTI.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2-Minute freeze; Ablation; Atrial fibrillation; Cryoballoon; Short tip; Time-to-isolation

Mesh:

Year:  2018        PMID: 29425568     DOI: 10.1016/j.ijcard.2017.11.039

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

1.  Earliest pulmonary vein potential-guided cryoballoon ablation for atrial fibrillation.

Authors:  Yoshiaki Mizutani; Masaaki Kanashiro; Yuichiro Makino; Akinori Satake; Wataru Suzuki; Masanari Kurobe; Kouji Mizutani; Hitoshi Ichimiya; Yasuhiro Uchida; Junji Watanabe; Satoshi Ichimiya; Yasuya Inden; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2019-07-11       Impact factor: 2.037

2.  Bronchial Injury - Yet Another Collateral Damage of Cryoablation.

Authors:  Amit Rout; Arjun Kanwal; William Han; Yousuf Kanjwal
Journal:  J Atr Fibrillation       Date:  2019-06-30

3.  Patient characteristics as predictors of recurrence of atrial fibrillation following cryoballoon ablation.

Authors:  Aakash A Bavishi; Rachel M Kaplan; Graham Peigh; Celso L Diaz; Jayson R Baman; Amar Trivedi; Jeremiah Wasserlauf; Mark J Shen; Prasongchai Sattayaprasert; Alexandru B Chicos; Susan Kim; Nishant Verma; Rishi Arora; Albert Lin; Bradley P Knight; Rod S Passman
Journal:  Pacing Clin Electrophysiol       Date:  2019-04-09       Impact factor: 1.976

4.  Association of the H2FPEF Risk Score with Recurrence of Atrial Fibrillation Following Pulmonary Vein Isolation.

Authors:  Ravi B Patel; Caitlin Somerville; Fei Fei Gong; Andrew C Peters; Sanjiv J Shah; Alexandru B Chicos; Susan Kim; Bradley P Knight; Albert Lin; Nishant Verma; Rod S Passman
Journal:  J Atr Fibrillation       Date:  2020-04-30

5.  Impact of atrial rhythm on pulmonary vein signals in cryoballoon ablation - Sinus rhythm predicts real-time observation of pulmonary vein isolation.

Authors:  Alexander Pott; Michael Baumhardt; Karolina Weinmann; Manuel Rattka; Tilman Stephan; Mirjam Keßler; Carlo Bothner; Kerstin Petscher; Wolfgang Rottbauer; Tillman Dahme
Journal:  Int J Cardiol Heart Vasc       Date:  2019-04-30

6.  Restoration of sinus rhythm by pulmonary vein isolation improves heart failure with preserved ejection fraction in atrial fibrillation patients.

Authors:  Manuel Rattka; Alexander Pott; Anna Kühberger; Karolina Weinmann; Dominik Scharnbeck; Tilman Stephan; Michael Baumhardt; Carlo Bothner; Mario Iturbe Orbe; Wolfgang Rottbauer; Tillman Dahme
Journal:  Europace       Date:  2020-09-01       Impact factor: 5.214

7.  Atrial fibrillation ablation in heart failure patients: improved systolic function after cryoballoon pulmonary vein isolation.

Authors:  Alexander Pott; Saskia Jäck; Christiane Schweizer; Michael Baumhardt; Tilman Stephan; Manuel Rattka; Karolina Weinmann; Carlo Bothner; Dominik Scharnbeck; Mirjam Keßler; Wolfgang Rottbauer; Tillman Dahme
Journal:  ESC Heart Fail       Date:  2020-06-24

8.  Predicting Phrenic Nerve Palsy in Patients Undergoing Atrial Fibrillation Ablation With the Cryoballoon-Does Sex Matter?

Authors:  Alexander Pott; Hagen Wirth; Yannick Teumer; Karolina Weinmann; Michael Baumhardt; Christiane Schweizer; Sinisa Markovic; Dominik Buckert; Carlo Bothner; Wolfgang Rottbauer; Tillman Dahme
Journal:  Front Cardiovasc Med       Date:  2021-12-14

9.  Incidence of Long-Term Pulmonary Vein Reconnection after a 2-Minute Cryoballoon Freeze for Pulmonary Vein Isolation-Invasive Insights of TTI-Dependent Cryoenergy Titration.

Authors:  Alexander Pott; Michael Baumhardt; Mohammad Al-Masalmeh; Alexander Wolf; Matthias Schiele; Christiane Schweizer; Carlo Bothner; Deniz Aktolga; Yannick Teumer; Karolina Weinmann; Wolfgang Rottbauer; Tillman Dahme
Journal:  J Cardiovasc Dev Dis       Date:  2022-08-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.